EPISODE · Jun 7, 2022 · 27 MIN
Fraud and Abuse: Latest False Claims Act Developments
from AHLA's Speaking of Health Law · host AHLA Podcasts
In this episode of AHLA's monthly series on fraud and abuse issues, Matthew Wetzel, Partner, Goodwin Procter, speaks with Robert S. Salcido, Partner, Akin Gump, about recent developments related to the False Claims Act (FCA). They discuss the ongoing split in circuit cases regarding when reasonable clinical judgements can be subject to the FCA, the government’s attack on joint ventures involving referral sources, and potentially amending the FCA’s damages provision to make it fairer to health care entities. Robert is the author of the brand-new Fourth Edition of AHLA’s False Claims Act & The Health Care Industry: Counseling & Litigation. From AHLA's Fraud and Abuse Practice Group. Sponsored by BRG.Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.
What this episode covers
In this episode of AHLA's monthly series on fraud and abuse issues, Matthew Wetzel, Partner, Goodwin Procter, speaks with Robert S. Salcido, Partner, Akin Gump, about recent developments related to the False Claims Act (FCA). They discuss the ongoing split in circuit cases regarding when reasonable clinical judgements can be subject to the FCA, the government’s attack on joint ventures involving referral sources, and potentially amending the FCA’s damages provision to make it fairer to health...
NOW PLAYING
Fraud and Abuse: Latest False Claims Act Developments
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m